MACOP-B regimen

Revision as of 15:49, 27 March 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for MACOP-B regimen

Articles

Most recent articles on MACOP-B regimen

Most cited articles on MACOP-B regimen

Review articles on MACOP-B regimen

Articles on MACOP-B regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on MACOP-B regimen

Images of MACOP-B regimen

Photos of MACOP-B regimen

Podcasts & MP3s on MACOP-B regimen

Videos on MACOP-B regimen

Evidence Based Medicine

Cochrane Collaboration on MACOP-B regimen

Bandolier on MACOP-B regimen

TRIP on MACOP-B regimen

Clinical Trials

Ongoing Trials on MACOP-B regimen at Clinical Trials.gov

Trial results on MACOP-B regimen

Clinical Trials on MACOP-B regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on MACOP-B regimen

NICE Guidance on MACOP-B regimen

NHS PRODIGY Guidance

FDA on MACOP-B regimen

CDC on MACOP-B regimen

Books

Books on MACOP-B regimen

News

MACOP-B regimen in the news

Be alerted to news on MACOP-B regimen

News trends on MACOP-B regimen

Commentary

Blogs on MACOP-B regimen

Definitions

Definitions of MACOP-B regimen

Patient Resources / Community

Patient resources on MACOP-B regimen

Discussion groups on MACOP-B regimen

Patient Handouts on MACOP-B regimen

Directions to Hospitals Treating MACOP-B regimen

Risk calculators and risk factors for MACOP-B regimen

Healthcare Provider Resources

Symptoms of MACOP-B regimen

Causes & Risk Factors for MACOP-B regimen

Diagnostic studies for MACOP-B regimen

Treatment of MACOP-B regimen

Continuing Medical Education (CME)

CME Programs on MACOP-B regimen

International

MACOP-B regimen en Espanol

MACOP-B regimen en Francais

Business

MACOP-B regimen in the Marketplace

Patents on MACOP-B regimen

Experimental / Informatics

List of terms related to MACOP-B regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:MACOP-B Regimen; Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen

Overview

MACOP-B regimen refers to a regimen consisting of methotrexate, doxorubicin (adriamycin), cyclophosphamide, vincristine (Oncovin) and prednisone, bleomycin used to treat aggressive forms of non-Hodgkin's lymphoma.[1][2]

Regimen

MMethotrexate

ADoxorubicin (Adriamycin)

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

BBleomycin

Indications

==References== 
  1. 1.0 1.1 De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E; et al. (2008). "MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma". Int J Radiat Oncol Biol Phys. 72 (4): 1154–60. doi:10.1016/j.ijrobp.2008.02.036. PMID 18472357.
  2. "NCI Thesaurus".
  3. "NCI Thesaurus".